161 – 170 of 327
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Why is the frequency of inhibitors increasing among Swedish children with severe hemophilia A?
- Contribution to journal › Published meeting abstract
-
Mark
Clinical issues in inhibitors
- Contribution to journal › Scientific review
-
Mark
The role of prophylaxis in bleeding disorders
- Contribution to journal › Scientific review
-
Mark
Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay (VWF:RCo) using a novel automated assay protocol
- Contribution to journal › Published meeting abstract
-
Mark
A retrospective study: of Octaplex (R) in the treatment of bleeding in patients with haemophilia A complicated by inhibitors
- Contribution to journal › Published meeting abstract
-
Mark
The necessity of having FVIII in VWF concentrates
(2010) 3rd Annual Congress of the European Association for Haemophilia and Allied Disorders In Haemophilia 16(2). p.400-400
- Contribution to journal › Published meeting abstract
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
- Contribution to journal › Scientific review
-
Mark
Comparison of several automated VWF:RCo assays for monitoring of patients treated with VWF/FVIII concentrates: improved performance with a new modified method
- Contribution to journal › Published meeting abstract
-
Mark
The combination of Octaplex (R) and Octanate (R) restores thrombin generation capacity in FVIII inhibitor plasma in-vitro
- Contribution to journal › Published meeting abstract
-
Mark
A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data
(2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.31-31
- Contribution to journal › Published meeting abstract
